DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

References

Ogiwara K, Nogami K, Matsumoto T, Shima M.
Tissue factor pathway inhibitor in activated prothrombin complex concentrates (aPCC) moderates the effectiveness of therapy in some severe hemophilia A patients with inhibitor.

Int J Hematol 2014;
99 (05) 577-587

Download Bibliographical Data

Access:
Access: